AU StockDetailed Quotes

Provided by Tiger Trade Technology Pte. Ltd.

4DMEDICAL LTD

3.830

-0.190-4.73%

Volume:3.08M

Turnover:11.99M

Market Cap:2.29B

PE:-9.28

High:3.980

Open:3.980

Low:3.810

Close:4.020

52wk High:7.550

52wk Low:0.472

Shares:597.56M

Float Shares:377.76M

Volume Ratio:0.73

T/O Rate:0.82%

Dividend:- -

Dividend Rate:- -

EPS(TTM):-0.413

EPS(LYR):-0.140

ROE:-1099.31%

ROA:-26.14%

PB:-80.58

PE(LYR):-27.36

Loading ...

Overview Company News Filings

BRIEF-4DMedical Says CT:VQ Receives CE Mark Certification For Commercial Use In European Union

BUZZ-Australia's 4DMedical hits record high on EU nod, premium placement

Stock Track | 4DMedical Ltd Soars 5.10% Intraday on CE Mark Certification for European Union Commercial Use

4DMedical Ltd - Ct:Vq Receives Ce Mark Certification for Commercial Use in European Union

THOMSON REUTERS

ASX Runners of the Week: Killi, Amplia, NuEnergy and 4D Medical

The West Australian

Why is everyone talking about 4DX shares this week?

Forget DroneShield and EOS, this ASX healthcare stock is up 15x in a year!

BUZZ-Australia's 4D Medical hits record high on tech deployment by Mayo Clinic

Why 4DMedical, Brazilian Rare Earths, Clarity, and Tuas shares are racing higher today

4DMedical Says Mayo Clinic Deploys Cardiothoracic Imaging Product; Shares Reach All-Time Peak

MT Newswires Live

Stock Track | 4DMedical Ltd Soars 39.74% on Mayo Clinic Technology Deployment

ASX 300 stock rockets 38% on 'landmark moment'

Up over 900%: Is it too late to buy this incredible ASX tech stock?

How Investors May Respond To 4DMedical (ASX:4DX) Losses Surging Despite Flat Half-Year Revenue

Simply Wall St.

4DMedical's CT:VQ Product to Contribute 'Meaningful' Revenue in Fiscal Year 2027, Says Jefferies, Shares Up 4%

MT Newswires Live

Stock Track | 4DMedical Soars 5.00% Intraday on FDA Approval and US$1.1 Billion Market Potential

The Bull Case For 4DMedical (ASX:4DX) Could Change Following CT:VQ Approval And Huge U.S. Market Potential

Simply Wall St.

4DMedical (ASX:4DX) Valuation Check After Half Year Results And CT:VQ Growth Opportunity

Simply Wall St.

BRIEF-4DMedical Posts Half-Year Net Loss A$153.9 Million

4DMedical Fiscal H1 Loss Widens, Revenue Remains Flat; Withholds Dividend

MT Newswires Live

{"basename":"","ssrTDKData":{"titleTemplate":"%s - Tiger Brokers","title":"Tiger Brokers HK | Online Trading in stocks, bonds & ETFS","description":"Discover Tiger Brokers HK, an online trading platform for stocks&ETFs, options&futures, bonds and crypto. Open an account to enjoy low commission trading today!","keywords":"tiger trading,tiger security,tiger broker hk,tigers co ltd,tiger trade hk,tiger brokers hk,stock broker,securities broker,online brokerage,hong kong broker,hk broker,online stock trading,online trading platform,stock trading platforms,trading application,stock trading,stock trading hong kong,buying stocks in hong kong,tiger brokers","social":{"ogDescription":"Discover Tiger Brokers HK, an online trading platform for stocks&ETFs, options&futures, bonds and crypto. Open an account to enjoy low commission trading today!","ogImage":"https://c1.itigergrowtha.com/portal5/static/media/og-logo.0a0bd8dc.png","ogUrl":"https://www.gotigerhk.com/stock/4DX.AU/news?page=5"},"companyName":"Tiger Brokers"},"pageData":{"isMobile":false,"isTiger":false,"isTTM":true,"region":"HKG","license":"TBHK","edition":"fundamental","symbol":"4DX.AU","isAnalysisPage":false},"__swrFallback__":{"@#url:\"https://hq.skytigris.cn/stock_info/detail/global\",params:#delay:true,,method:\"POST\",data:#items:@#symbol:\"4DX.AU\",,,,,undefined,":{"symbol":"4DX.AU","market":"AU","secType":"STK","nameCN":"4DMEDICAL LTD","latestPrice":3.83,"timestamp":1787292720000,"preClose":4.02,"halted":0,"volume":3079212,"delay":0,"changeRate":-0.04726368159203968,"nameEN":"4DMEDICAL LTD","floatShares":377762864,"shares":597559121,"eps":-0.412693,"marketStatus":"Not Yet Opened","change":-0.19,"latestTime":"08-21 16:12:00 AEST","open":3.98,"high":3.98,"low":3.81,"amount":11985873,"amplitude":0.042289,"askPrice":0,"askSize":0,"bidPrice":0,"bidSize":0,"shortable":3,"etf":0,"ttmEps":-0.412693,"tradingStatus":0,"nextMarketStatus":{"tag":"Open","tradingStatus":0,"beginTime":1787529600000},"marketStatusCode":0,"adr":0,"exchange":"ASX","adjPreClose":4.02,"openAndCloseTimeList":[[1787270400000,1787292000000]],"volumeRatio":0.7300431006290026,"lotSize":1,"tradeCurrency":"AUD","auctionPricing":{"symbol":"4DX.AU","preClose":4.02,"auctionPrice":3.83,"auctionVolume":238736,"auction":3,"marketStatus":"盘后竞价","timestamp":1787292600246}},"@#url:\"https://hq.skytigris.cn/stock_info/fundamental/all\",params:#delay:true,,method:\"POST\",data:#items:@#symbol:\"4DX.AU\",,,,,undefined,":{"symbol":"4DX.AU","floatShares":377762864,"roa":"-26.14%","roe":"-1099.31%","lyrEps":-0.14,"volumeRatio":0.7300431006290026,"shares":597559121,"dividePrice":0,"high":3.98,"amplitude":0.042289,"preClose":4.02,"low":3.81,"week52Low":0.472,"pbRate":"-80.58","psRate":"393.89","week52High":7.55,"institutionHeld":0,"latestPrice":3.83,"eps":-0.412693,"divideRate":0,"volume":3079212,"delay":0,"ttmEps":-0.412693,"open":3.98,"prevYearClose":3.93,"prevWeekClose":3.83,"prevMonthClose":3.63,"prevQuarterClose":4.53,"fiveDayClose":3.64,"twentyDayClose":3.11,"sixtyDayClose":3.34},"@#url:\"https://hq.skytigris.cn/fundamental/corporate_actions/details/4DX.AU\",params:#limit:5,,,undefined,":[],"@#url:\"https://hq.skytigris.cn/fundamental/dividend/history\",params:#symbol:\"4DX.AU\",market:\"AU\",,,undefined,":[],"$inf$@#url:\"https://stock-news.skytigris.cn/v2/news/list\",params:#symbols:\"4DX.AU\",pageSize:20,pageCount:5,lang_content:\"en\",edition:\"fundamental\",,,undefined,":[{"items":[{"id":"2622813715","title":"BRIEF-4DMedical Says CT:VQ Receives CE Mark Certification For Commercial Use In European Union","url":"https://stock-news.laohu8.com/highlight/detail?id=2622813715","media":"Reuters","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2622813715?lang=en_us&edition=fundamental","pubTime":"2026-03-27 09:26","pubTimestamp":1774574762,"startTime":"0","endTime":"0","summary":"BRIEF-4DMedical Says CT:VQ Receives CE Mark Certification For Commercial Use In European UnionMarch 27 (Reuters) - 4DMedical Ltd 4DX.AX:CT:VQ RECEIVES CE MARK CERTIFICATION FOR COMMERCIAL USE IN EUROPEAN UNIONFurther company coverage: 4DX.AX ((Reuters.Briefs@thomsonreuters.com;))","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260327:nFWN40E16Y:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["4DX.AU","BK7094"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2622818047","title":"BUZZ-Australia's 4DMedical hits record high on EU nod, premium placement","url":"https://stock-news.laohu8.com/highlight/detail?id=2622818047","media":"Reuters","labels":["shareholding","corporation"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2622818047?lang=en_us&edition=fundamental","pubTime":"2026-03-27 09:00","pubTimestamp":1774573254,"startTime":"0","endTime":"0","summary":"BUZZ-Australia's 4DMedical hits record high on EU nod, premium placement** 4DMedical 4DX.AX soars as much as 20.2% to record high of A$7.55; set for its eighth consecutive session of gains** Stock up 53.3% so far this week; set for best week in more than three months** Medical tech maker says its imaging software, CT:VQ, received CE mark certification for commercial use in European Union** Completes A$83 mln  private placement** Offer price of A$5.90/share represents 37.2% premium to last close** Proceeds will fund commercial launch of CT:VQ across Europe, international markets** YTD, 4DX up 68.5%  ","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260327:nL6N40F02D:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"2","news_top_title":null,"news_tag":"shareholding,corporation","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK7094","4DX.AU"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1179869828","title":"Stock Track | 4DMedical Ltd Soars 5.10% Intraday on CE Mark Certification for European Union Commercial Use","url":"https://stock-news.laohu8.com/highlight/detail?id=1179869828","media":"Stock Track","labels":["movement"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1179869828?lang=en_us&edition=fundamental","pubTime":"2026-03-27 07:08","pubTimestamp":1774566505,"startTime":"0","endTime":"0","summary":"4DMedical Ltd's stock soared 5.10% during intraday trading on Friday, following a significant regulatory milestone for the company.The surge comes after the company announced it received CE Mark...","market":"sg","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"movement","news_rank":0,"length":0,"strategy_id":0,"source":"ai_movement_en","symbols":["4DX.AU"],"isVideo":false,"video":null,"gpt_icon":1},{"id":"2622389210","title":"4DMedical Ltd - Ct:Vq Receives Ce Mark Certification for Commercial Use in European Union","url":"https://stock-news.laohu8.com/highlight/detail?id=2622389210","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2622389210?lang=en_us&edition=fundamental","pubTime":"2026-03-27 06:56","pubTimestamp":1774565803,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260326:nFWN40E16Y:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["4DX.AU","BK7094"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2622810960","title":"ASX Runners of the Week: Killi, Amplia, NuEnergy and 4D Medical","url":"https://stock-news.laohu8.com/highlight/detail?id=2622810960","media":"The West Australian","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2622810960?lang=en_us&edition=fundamental","pubTime":"2026-03-27 06:12","pubTimestamp":1774563129,"startTime":"0","endTime":"0","summary":"The Bulls N’ Bears ASX Runner of the Week is… Killi Resources, after a boardroom makeover, lured in ex-Fortescue boss Nev Power for a bold tilt at its Mt Rawdon West, QLD gold-copper play. ","market":"us","thumbnail":"https://images.thewest.com.au/publication/C-22058751/f3ba145e5bde0aa97d4b38a2ae55d7e52f82c4d9.jpg","type":0,"news_type":0,"thumbnails":["https://images.thewest.com.au/publication/C-22058751/f3ba145e5bde0aa97d4b38a2ae55d7e52f82c4d9.jpg"],"rights":{"source":"thewest_stock","url":"https://thewest.com.au/business/bulls-n-bears/asx-runners-of-the-week-killi-amplia-nuenergy-and-4d-medical-c-22058751","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://thewest.com.au/business/bulls-n-bears/asx-runners-of-the-week-killi-amplia-nuenergy-and-4d-medical-c-22058751","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"thewest_stock","symbols":["4DX.AU","CEI","BK7142","BK4213","BK4585","XME","BK4182","BK4535","NGY.AU","VDE","PSC.AU","KLI.AU","BK4588","BK7094","BK7067","ATX.AU","PSC","BK7095"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2622388368","title":"Why is everyone talking about 4DX shares this week?","url":"https://stock-news.laohu8.com/highlight/detail?id=2622388368","media":"MotleyFool","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2622388368?lang=en_us&edition=fundamental","pubTime":"2026-03-26 12:25","pubTimestamp":1774499150,"startTime":"0","endTime":"0","summary":"4DMedical Ltd  shares have jumped another 2.3% higher in Thursday afternoon trade. At the time of writing, the shares are changing hands at $6.37 a piece.The uptick means the shares have now rocketed 55% over the past week. They're now up a huge 71% over the past month and are 40% higher over the year to date.Most impressively, 4DX shares are 1,890% higher than this time 12 months ago, driven by regulatory approvals and a portfolio of signed contracts with hospitals and medical providers.The company saw its share price explode in 2025 after its flagship product, CT:VQ, received regulatory approvals. It was quickly implemented and adopted through partnerships and commercial contracts with healthcare organisations.4DMedical has already signed contracts with hospitals and medical providers, primarily across the US. Stanford University, the University of Miami, Cleveland Clinic, and UC San Diego Health have all rolled out the technology at their centres.What's clear though, is that the sha","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"motleyfoolau_stock","url":"https://www.fool.com.au/2026/03/26/why-is-everyone-talking-about-4dx-shares-this-week/","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.fool.com.au/2026/03/26/why-is-everyone-talking-about-4dx-shares-this-week/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"motleyfoolau_stock","symbols":["4DX.AU","BK7094"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2622001089","title":"Forget DroneShield and EOS, this ASX healthcare stock is up 15x in a year!","url":"https://stock-news.laohu8.com/highlight/detail?id=2622001089","media":"MotleyFool","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2622001089?lang=en_us&edition=fundamental","pubTime":"2026-03-26 03:53","pubTimestamp":1774468400,"startTime":"0","endTime":"0","summary":"4DMedical Ltd  shares stole the spotlight on Wednesday, surging 34% to a record high and capping off one of the most extraordinary runs on the ASX.Over the past year, defence stocks have grabbed the headlines with Droneshield Ltd up 330% and Electro Optic Systems Ltd  up 540% but the returns from 4DMedical, up a staggering 1,630%, are hard to ignore.What is driving such an astronomical share price increase?The catalyst for the latest move is the deployment of 4DMedical's CT:VQ technology at the Mayo Clinic in the United States, widely regarded as one of the best hospitals in the world.This is a high credibility signal. When an institution like Mayo adopts a new technology, it carries weight across the broader healthcare system.There is no doubt that 4DMedical is one of the hottest stocks on the ASX right now. The rally reflects growing confidence that the company is moving beyond a promising technology story into early commercial execution.With a market cap exceeding $3Billion, expecta","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"motleyfoolau_stock","url":"https://www.fool.com.au/2026/03/26/forget-droneshield-and-eos-this-asx-healthcare-stock-is-up-15x-in-a-year/","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.fool.com.au/2026/03/26/forget-droneshield-and-eos-this-asx-healthcare-stock-is-up-15x-in-a-year/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"2","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"motleyfoolau_stock","symbols":["BK7115","IXJ","EOS.AU","4DX.AU","BK4585","EOS","BK7094","BK4588","BK4550","VHT"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2622004135","title":"BUZZ-Australia's 4D Medical hits record high on tech deployment by Mayo Clinic","url":"https://stock-news.laohu8.com/highlight/detail?id=2622004135","media":"Reuters","labels":["corporation"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2622004135?lang=en_us&edition=fundamental","pubTime":"2026-03-25 12:51","pubTimestamp":1774414288,"startTime":"0","endTime":"0","summary":"BUZZ-Australia's 4D Medical hits record high on tech deployment by Mayo Clinic** 4DMedical 4DX.AX soars as much as 39.7% to lifetime high of A$6.47** Stock logs largest intraday pct jump since September 2025** Medical tech maker says U.S. medical centre Mayo Clinic has initiated deployment of co's CT:VQ tech for ventilation, perfusion analysis** Adds deployment represents one of the most significant institutional endorsements to date for co** More than 24 million shares traded, 3.7x the 30-day avg** YTD, 4DX up 58.9%  ","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260325:nL4N40D0E9:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"corporation","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK7094","4DX.AU"],"isVideo":false,"video":null,"gpt_icon":1},{"id":"2622043920","title":"Why 4DMedical, Brazilian Rare Earths, Clarity, and Tuas shares are racing higher today","url":"https://stock-news.laohu8.com/highlight/detail?id=2622043920","media":"MotleyFool","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2622043920?lang=en_us&edition=fundamental","pubTime":"2026-03-25 10:35","pubTimestamp":1774406118,"startTime":"0","endTime":"0","summary":"In afternoon trade, theS&P/ASX 200 Index is on course to record a strong gain. At the time of writing, the benchmark index is up 1.95% to 8,544.3 points.Four ASX shares that are rising more than most today are listed below. Here's why they are racing higher:. The 4DMedical share price is up 34% to $6.21. Investors have been buying this respiratory imaging technology company's shares after it made a big announcement. 4DMedical revealed that its CT:VQ technology has been deployed at the Mayo Clinic in the United States. The company's managing director and CEO, Andreas Fouras, commented: \"Mayo's deployment is uniquely significant. When the world's number one hospital chooses to use your technology, it sends the strongest possible signal to the entire U.S. healthcare market about the clinical value and readiness of CT:VQ.\". The Tuas share price is up 5.5% to $6.33. This morning, this Singapore-based telco released its half-year results for FY 2026. Tuas revealed a 25.5% increase in revenue","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"motleyfoolau_stock","url":"https://www.fool.com.au/2026/03/25/why-4dmedical-brazilian-rare-earths-clarity-and-tuas-shares-are-racing-higher-today/","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.fool.com.au/2026/03/25/why-4dmedical-brazilian-rare-earths-clarity-and-tuas-shares-are-racing-higher-today/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"motleyfoolau_stock","symbols":["XJO.AU","CU6.AU","TUA.AU","BRE.AU","BK7096","BK7042","BK7095","BK7094","4DX.AU"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2622701475","title":"4DMedical Says Mayo Clinic Deploys Cardiothoracic Imaging Product; Shares Reach All-Time Peak","url":"https://stock-news.laohu8.com/highlight/detail?id=2622701475","media":"MT Newswires Live","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2622701475?lang=en_us&edition=fundamental","pubTime":"2026-03-25 08:14","pubTimestamp":1774397661,"startTime":"0","endTime":"0","summary":"4DMedical  said the Mayo Clinic started deploying its CT:VQ cardiothoracic imaging product for ventilation and perfusion analysis, according to a Wednesday Australian bourse filing.The initial deployment will support clinical workflow integration and build clinician familiarity with the product, with potential to expand to full commercial terms, the filing said.4DMedical's shares jumped over 31% in recent trading on Wednesday and earlier reached an all-time peak.","market":"sg","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.mtnewswires.com/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"2","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":"mtnewswires_news","symbols":["4DX.AU","BK7094","SKIS"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1184990425","title":"Stock Track | 4DMedical Ltd Soars 39.74% on Mayo Clinic Technology Deployment","url":"https://stock-news.laohu8.com/highlight/detail?id=1184990425","media":"Stock Track","labels":["movement"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1184990425?lang=en_us&edition=fundamental","pubTime":"2026-03-25 07:28","pubTimestamp":1774394912,"startTime":"0","endTime":"0","summary":"4DMedical Ltd's stock soared 39.74% intraday on Wednesday, reaching record highs.The surge follows the company's announcement that its CT:VQ respiratory imaging technology has been deployed at the...","market":"sg","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"2","news_top_title":null,"news_tag":"movement","news_rank":0,"length":0,"strategy_id":0,"source":"ai_movement_en","symbols":["4DX.AU"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2622466011","title":"ASX 300 stock rockets 38% on 'landmark moment'","url":"https://stock-news.laohu8.com/highlight/detail?id=2622466011","media":"MotleyFool","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2622466011?lang=en_us&edition=fundamental","pubTime":"2026-03-25 07:26","pubTimestamp":1774394784,"startTime":"0","endTime":"0","summary":"4DMedical Ltd  shares are rocketing on Wednesday morning.In early trade, the ASX 300 stock is up a massive 38% to a record-high of $6.40.Why is this ASX 300 stock rising today?According to the release, 4DMedical's CT:VQ technology has been deployed at the Mayo Clinic in the United States.The release reveals that the Mayo Clinic, which is widely regarded as one of the world's leading hospitals, has entered into an agreement to use CT:VQ for ventilation and perfusion analysis.The others are Stanford, Cleveland Clinic, UC San Diego Health, University of Chicago Medicine, and the University of Miami.The ASX 300 stock's managing director and CEO, Andreas Fouras, described the deployment as a landmark moment for the company. He said:. Combined with our existing network of elite AMC reference sites, and the Philips partnership, we are building an unassailable platform for CT:VQ adoption.","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"motleyfoolau_stock","url":"https://www.fool.com.au/2026/03/25/asx-300-stock-rockets-38-on-landmark-moment/","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.fool.com.au/2026/03/25/asx-300-stock-rockets-38-on-landmark-moment/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"2","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"motleyfoolau_stock","symbols":["4DX.AU","BK7094"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2620828300","title":"Up over 900%: Is it too late to buy this incredible ASX tech stock?","url":"https://stock-news.laohu8.com/highlight/detail?id=2620828300","media":"MotleyFool","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2620828300?lang=en_us&edition=fundamental","pubTime":"2026-03-18 11:11","pubTimestamp":1773803486,"startTime":"0","endTime":"0","summary":"4DMedical Ltd  shares are trading 2% higher in afternoon trade on Wednesday. At the time of writing, the shares are trading at $3.87 each. The shares are now down 14.10% year to date.The decline might look concerning on the surface, but it has barely dented the company's gains over the past 12 months. At the time of writing, 4DMedical shares are trading an enormous 950% higher than this time last year.What has happened to the ASX tech stock's shares?4DMedical is a healthcare technology company that develops imaging software for healthcare providers to analyse airflow through the lungs. It helps identify and treat lung andrespiratory diseases ranging from asthma to lung cancer.The company saw its share price explode in 2025 after its flagship product, CT:VQ, received regulatory approvals. It was quickly implemented and adopted through partnerships and commercial contracts with healthcare organisations.This month, 4DMedical was also added to the All Ordinaries Index  and the S&P/ASX 300 ","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"motleyfoolau_stock","url":"https://www.fool.com.au/2026/03/18/up-over-900-is-it-too-late-to-buy-this-incredible-asx-tech-stock/","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.fool.com.au/2026/03/18/up-over-900-is-it-too-late-to-buy-this-incredible-asx-tech-stock/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"motleyfoolau_stock","symbols":["XKO.AU","4DX.AU","XAO.AU","BK7094"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2618598641","title":"How Investors May Respond To 4DMedical (ASX:4DX) Losses Surging Despite Flat Half-Year Revenue","url":"https://stock-news.laohu8.com/highlight/detail?id=2618598641","media":"Simply Wall St.","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2618598641?lang=en_us&edition=fundamental","pubTime":"2026-03-10 13:17","pubTimestamp":1773119826,"startTime":"0","endTime":"0","summary":"In late February 2026, 4DMedical Limited reported half-year results to 31 December 2025, with sales of A$2.85 million, broadly unchanged from A$2.90 million a year earlier, but net loss widening sharply to A$154.14 million and basic loss per share reaching A$0.311.\nThe stark contrast between relatively stable revenue and a very large increase in losses highlights how cost structure and investment spending are weighing on profitability.\nNext, we'll examine how this sharp widening in net loss...","market":"us","thumbnail":"https://images.simplywall.st/asset/industry/9551730-choice2-main-header/1585186975683","type":0,"news_type":0,"thumbnails":["https://images.simplywall.st/asset/industry/9551730-choice2-main-header/1585186975683"],"rights":{"source":"simplywall_highlight","url":"https://simplywall.st/stocks/au/healthcare/asx-4dx/4dmedical-shares/news/how-investors-may-respond-to-4dmedical-asx4dx-losses-surging","rn_cache_url":null,"directOrigin":true},"property":["earning"],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://simplywall.st/stocks/au/healthcare/asx-4dx/4dmedical-shares/news/how-investors-may-respond-to-4dmedical-asx4dx-losses-surging","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"simplywall_highlight","symbols":["ISBC","4DX.AU"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2616391390","title":"4DMedical's CT:VQ Product to Contribute 'Meaningful' Revenue in Fiscal Year 2027, Says Jefferies, Shares Up 4%","url":"https://stock-news.laohu8.com/highlight/detail?id=2616391390","media":"MT Newswires Live","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2616391390?lang=en_us&edition=fundamental","pubTime":"2026-03-03 10:44","pubTimestamp":1772505841,"startTime":"0","endTime":"0","summary":"4DMedical's  fiscal first-half results did not include revenue from its CT:VQ products, as expected, but a more \"meaningful\" revenue contribution is expected in fiscal year 2027, according to a Monday Jefferies note.The company reported a Friday fiscal first-half loss of AU$0.259 per share, widening from a loss of AU$0.025 a year earlier. Revenue was AU$2.9 million, compared with AU$2.9 million a year earlier.Following the partnership agreement with Philips and the expiry of introductory pricing at five academic medical centers, initial revenue from the products is expected to emerge in the second half of fiscal year 2026, the note added.Jefferies maintained a buy rating on 4DMedical and raised its price target to AU$4.90 from AU$2.50.The company's shares rose 4% in recent Tuesday trade.","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.mtnewswires.com/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":"mtnewswires_news","symbols":["BK7094","4DX.AU"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1154718745","title":"Stock Track | 4DMedical Soars 5.00% Intraday on FDA Approval and US$1.1 Billion Market Potential","url":"https://stock-news.laohu8.com/highlight/detail?id=1154718745","media":"Stock Track","labels":["movement"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1154718745?lang=en_us&edition=fundamental","pubTime":"2026-03-02 08:08","pubTimestamp":1772410109,"startTime":"0","endTime":"0","summary":"4DMedical Limited's stock surged 5.00% during Monday's intraday trading session, reflecting heightened investor interest in the medical imaging company.The significant price movement appears to be...","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"movement","news_rank":0,"length":0,"strategy_id":0,"source":"ai_movement_en","symbols":["4DX.AU"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2616786878","title":"The Bull Case For 4DMedical (ASX:4DX) Could Change Following CT:VQ Approval And Huge U.S. Market Potential","url":"https://stock-news.laohu8.com/highlight/detail?id=2616786878","media":"Simply Wall St.","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2616786878?lang=en_us&edition=fundamental","pubTime":"2026-03-01 22:26","pubTimestamp":1772375180,"startTime":"0","endTime":"0","summary":"In February 2026, 4DMedical Limited reported half-year results to 31 December 2025, with sales of A$2.85 million and a net loss of A$154.14 million, alongside basic loss per share from continuing operations of A$0.311 and diluted loss per share of A$0.259.\nDespite the wider reported loss, the company highlighted an improved adjusted net loss, strong pro forma cash position, and a newly approved CT:VQ imaging product targeting an initial addressable U.S. market exceeding US$1.10 billion...","market":"us","thumbnail":"https://images.simplywall.st/asset/industry/9551730-choice2-main-header/1585186975683","type":0,"news_type":0,"thumbnails":["https://images.simplywall.st/asset/industry/9551730-choice2-main-header/1585186975683"],"rights":{"source":"simplywall_highlight","url":"https://simplywall.st/stocks/au/healthcare/asx-4dx/4dmedical-shares/news/the-bull-case-for-4dmedical-asx4dx-could-change-following-ct","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://simplywall.st/stocks/au/healthcare/asx-4dx/4dmedical-shares/news/the-bull-case-for-4dmedical-asx4dx-could-change-following-ct","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":"simplywall_highlight","symbols":["BK7094","4DX.AU"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2614813961","title":"4DMedical (ASX:4DX) Valuation Check After Half Year Results And CT:VQ Growth Opportunity","url":"https://stock-news.laohu8.com/highlight/detail?id=2614813961","media":"Simply Wall St.","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2614813961?lang=en_us&edition=fundamental","pubTime":"2026-02-28 14:28","pubTimestamp":1772260090,"startTime":"0","endTime":"0","summary":"4DMedical (ASX:4DX) is back in focus after its half-year results, where the company reported an improved adjusted net loss, a solid cash position, and highlighted its recently approved CT:VQ product.\nSee our latest analysis for 4DMedical.\nAt a latest share price of A$4.00, 4DMedical has seen a 12.68% 1 month share price return and a 133.92% 3 month share price return, while its 1 year total shareholder return is very large. This suggests momentum has been building around the CT:VQ rollout and...","market":"sg","thumbnail":"https://images.simplywall.st/asset/industry/9551730-choice2-main-header/1585186975683","type":0,"news_type":0,"thumbnails":["https://images.simplywall.st/asset/industry/9551730-choice2-main-header/1585186975683"],"rights":{"source":"simplywall_highlight","url":"https://simplywall.st/stocks/au/healthcare/asx-4dx/4dmedical-shares/news/4dmedical-asx4dx-valuation-check-after-half-year-results-and","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://simplywall.st/stocks/au/healthcare/asx-4dx/4dmedical-shares/news/4dmedical-asx4dx-valuation-check-after-half-year-results-and","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":"simplywall_highlight","symbols":["BK7094","4DX.AU"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2614569009","title":"BRIEF-4DMedical Posts Half-Year Net Loss A$153.9 Million","url":"https://stock-news.laohu8.com/highlight/detail?id=2614569009","media":"Reuters","labels":["express"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2614569009?lang=en_us&edition=fundamental","pubTime":"2026-02-27 09:41","pubTimestamp":1772156478,"startTime":"0","endTime":"0","summary":"BRIEF-4DMedical Posts Half-Year Net Loss A$153.9 MillionFeb 27 (Reuters) - 4DMedical Ltd 4DX.AX:H1 NET INCOME AUD -153.9 MILLIONHY REVENUE FROM ORDINARY ACTIVITIES A$2.9 MILLIONFurther company coverage: 4DX.AX ((Reuters.Briefs@thomsonreuters.com;))","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260227:nPLXEA08DC:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-2","news_top_title":null,"news_tag":"express","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK7094","4DX.AU"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2614320070","title":"4DMedical Fiscal H1 Loss Widens, Revenue Remains Flat; Withholds Dividend","url":"https://stock-news.laohu8.com/highlight/detail?id=2614320070","media":"MT Newswires Live","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2614320070?lang=en_us&edition=fundamental","pubTime":"2026-02-27 07:09","pubTimestamp":1772147391,"startTime":"0","endTime":"0","summary":"4DMedical  reported Friday fiscal first-half loss of AU$0.259 per share, widening from a loss of AU$0.025 a year earlier.Revenue for the six months ended Dec. 31, 2025, was AU$2.9 million, compared with AU$2.9 million a year earlier. Analysts surveyed by FactSet expected AU$3 million.The board continues to not recommend or declare a dividend.","market":"sg","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.mtnewswires.com/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":"mtnewswires_news","symbols":["4DX.AU","BK7094"],"isVideo":false,"video":null,"gpt_icon":0}],"pageSize":20,"totalPage":6,"pageCount":5,"totalSize":103,"code":"91000000","status":"200"}]}}